Basic Information

Corridor Pharmaceuticals, Inc.
2330 W JOPPA RD, STE 330
LUTHERVILLE, MD, 21093-4690

Company Profile


Additional Details

Field Value
DUNS: 824770791
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a

  1. Targeting endothelial arginase to treat diabetes-associated vascular dysfunction

    Amount: $365,333.00

    DESCRIPTION (provided by applicant): The product that will result from this STTR is ABH (2(S)-amino-6-boronohexanoic acid), a potent small molecule inhibitor of the enzyme arginase, for treating vasc ...

    STTR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government